相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NAFLD and cardiovascular diseases: a clinical review
Philipp Kasper et al.
CLINICAL RESEARCH IN CARDIOLOGY (2021)
Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
Stephen A. Harrison et al.
GASTROENTEROLOGY (2021)
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
Sven Francque et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status Results From the EMPEROR-Reduced Trial
Stefan D. Anker et al.
CIRCULATION (2021)
Liver-targeting drugs and their effect on blood glucose and hepatic lipids
Amalia Gastaldelli et al.
DIABETOLOGIA (2021)
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Philip N. Newsome et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial
Magnus Holmer et al.
JHEP REPORTS (2021)
Effects of Resmetirom on Noninvasive Endpoints in a 36-Week Phase 2 Active Treatment Extension Study in Patients With NASH
Stephen A. Harrison et al.
HEPATOLOGY COMMUNICATIONS (2021)
Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: A propensity matched analysis
Minyoung Kwak et al.
AMERICAN JOURNAL OF SURGERY (2020)
Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight Loss
Ahmad Al-Mrabeh et al.
CELL METABOLISM (2020)
Bariatric Surgery Rapidly Decreases Cardiac Dietary Fatty Acid Partitioning and Hepatic Insulin Resistance Through Increased Intra-abdominal Adipose Tissue Storage and Reduced Spillover in Type 2 Diabetes
Anne-Marie Carreau et al.
DIABETES (2020)
Dapagliflozin plus saxagliptin add-on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes
Lars Johansson et al.
DIABETES OBESITY & METABOLISM (2020)
Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes
Amalia Gastaldelli et al.
DIABETES OBESITY & METABOLISM (2020)
IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
Hua Bian et al.
ENDOCRINE PRACTICE (2020)
Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study
Vlad Ratziu et al.
HEPATOLOGY (2020)
Multicenter Validation of Association Between Decline in MRI-PDFF and Histologic Response in NASH
Rohit Loomba et al.
HEPATOLOGY (2020)
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison et al.
JOURNAL OF HEPATOLOGY (2020)
Anti-NASH Drug Development Hitches a Lift on PPAR Agonism
Joost Boeckmans et al.
CELLS (2020)
Nonalcoholic Steatohepatitis: A Review
Adam C. Sheka et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Noninvasive Diagnosis of NAFLD and NASH
Valeria Annarita Piazzolla et al.
CELLS (2020)
Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
Anne Fougerat et al.
CELLS (2020)
HM15211, a novel GLP-1/GIP/Glucagon triple-receptor co-agonist significantly reduces liver fat and body weight in obese subjects with non-alcoholic fatty liver disease: A Phase 1b/2a, multi-center, randomized, placebo-controlled trial
Manal Abdelmalek et al.
JOURNAL OF HEPATOLOGY (2020)
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Patricia Rada et al.
CELL DEATH & DISEASE (2020)
SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews
Shih-Chieh Shao et al.
BMJ OPEN DIABETES RESEARCH & CARE (2020)
BYPASS VS. SLEEVE AND ITS EFFECTS IN NON-ALCOHOLIC FATTY LIVER DISEASE: WHAT IS THE BEST TECHNIQUE?
Marcos Bertozzi Goldoni et al.
ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY (2020)
A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study
Francque M. Sven et al.
CONTEMPORARY CLINICAL TRIALS (2020)
Observed changes in brown, white, hepatic and pancreatic fat after bariatric surgery: Evaluation with MRI
Steve C. N. Hui et al.
EUROPEAN RADIOLOGY (2019)
Pioglitazone Therapy in Patients With Stroke and Prediabetes A Post Hoc Analysis of the IRIS Randomized Clinical Trial
J. David Spence et al.
JAMA NEUROLOGY (2019)
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
Michael E. J. Lean et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis
Ke Pu et al.
BMC GASTROENTEROLOGY (2019)
Understanding the mechanisms of reversal of type 2 diabetes
Roy Taylor et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity
Philip Newsome et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
A double-blind, placebo-controlled, randomised trial to assess the effect of liraglutide on ectopic fat accumulation in South Asian type 2 diabetes patients
Huub J. van Eyk et al.
CARDIOVASCULAR DIABETOLOGY (2019)
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2019)
Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
Annette Brandt et al.
SCIENTIFIC REPORTS (2019)
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study
Qiuhong Gong et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria
Dustin Baldwin et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2019)
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen A. Harrison et al.
LANCET (2019)
New insight into the mechanisms of ectopic fat deposition improvement after bariatric surgery
Giulia Angelini et al.
SCIENTIFIC REPORTS (2019)
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Myriam Alexander et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Sven Francque et al.
ADVANCES IN THERAPY (2019)
Evaluation of Dietary Approaches for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review
Naba Saeed et al.
NUTRIENTS (2019)
From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
Amalia Gastaldelli et al.
JHEP REPORTS (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
Juan Pablo Arab et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
How bariatric surgery affects liver volume and fat density in NAFLD patients
Ran B. Luo et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2018)
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
Alessandro Mantovani et al.
DIABETES CARE (2018)
Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
Mohammad Shafi Kuchay et al.
DIABETES CARE (2018)
Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
Jan W. Eriksson et al.
DIABETOLOGIA (2018)
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
Subodh Verma et al.
DIABETOLOGIA (2018)
Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD
Cyrielle Caussy et al.
HEPATOLOGY (2018)
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
Scott L. Friedman et al.
HEPATOLOGY (2018)
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
Michael E. J. Lean et al.
LANCET (2018)
In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control
Katherine J. P. Schwenger et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2018)
Laparoscopic Sleeve Gastrectomy Resolves NAFLD: Another Formal Indication for Bariatric Surgery?
Carlos Martin Esquivel et al.
OBESITY SURGERY (2018)
IMPAIRED ADIPOGENESIS AND DYSFUNCTIONAL ADIPOSE TISSUE IN HUMAN HYPERTROPHIC OBESITY
Ann Hammarstedt et al.
PHYSIOLOGICAL REVIEWS (2018)
Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score)
Witigo von Schoenfels et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2018)
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
Juan Pablo Frias et al.
LANCET (2018)
Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
Arun Sanyal et al.
LANCET (2018)
Increased Liver Fatty Acid Uptake Is Partly Reversed and Liver Fat Content Normalized After Bariatric Surgery
Heidi Immonen et al.
DIABETES CARE (2018)
Radiographic Improvement of Hepatic Steatosis After Laparoscopic Roux-en-Y Gastric Bypass
Joshua S. Winder et al.
OBESITY SURGERY (2017)
Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
Oscar Chavez-Talavera et al.
GASTROENTEROLOGY (2017)
Treatment of NAFLD with diet, physical activity and exercise
Manuel Romero-Gómez et al.
JOURNAL OF HEPATOLOGY (2017)
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Carel W. le Roux et al.
LANCET (2017)
Bariatric Surgery versus Intensive Medical Therapy for Diabetes-5-Year Outcomes
Philip R. Schauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: Magnetic Resonance Imaging Is an Effective, Non-invasive Method to Evaluate Changes in the Liver Fat Fraction
Dennis M. Hedderich et al.
OBESITY SURGERY (2017)
Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial
Tisha R. Joy et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Efficacy and safety of glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Yajie Dong et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: A randomized controlled trial
Sulin Cheng et al.
SCIENTIFIC REPORTS (2017)
The future of diagnosing NASH - could a simple blood test be the key?
Sven Francque et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Clinical Endpoints and Adaptive Clinical Trials in Precirrhotic Nonalcoholic Steatohepatitis: Facilitating Development Approaches for an Emerging Epidemic
Claudia Filozof et al.
HEPATOLOGY COMMUNICATIONS (2017)
The New-Generation Pan-Peroxisome Proliferator-Activated Receptor Agonist IVA337 Protects the Liver From Metabolic Disorders and Fibrosis
Guillaume Wettstein et al.
HEPATOLOGY COMMUNICATIONS (2017)
PPARs and nonalcoholic fatty liver disease
Kim H. H. Liss et al.
BIOCHIMIE (2017)
Effects of a Sodium-Glucose Cotransporter 2 Inhibitor in Nonalcoholic Fatty Liver Disease Complicated by Diabetes Mellitus: Preliminary Prospective Study Based On Serial Liver Biopsies
Norio Akuta et al.
HEPATOLOGY COMMUNICATIONS (2017)
Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial
David Houghton et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus A Randomized Trial
Kenneth Cusi et al.
ANNALS OF INTERNAL MEDICINE (2016)
Editorial Board
Clinical Gastroenterology and Hepatology (2016)
Exercise-based Interventions for Nonalcoholic Fatty Liver Disease: A Meta-analysis and Meta-regression
Lorenzo A. Orci et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery
Nicolas Goossens et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Pharmacological Approaches in the Treatment and Maintenance of Weight Loss
Luc Van Gaal et al.
DIABETES CARE (2016)
Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery
Rachel L. Batterham et al.
DIABETES CARE (2016)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Pathophysiology of Non Alcoholic Fatty Liver Disease
Salvatore Petta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis
Melissa A. Linden et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Matthew James Armstrong et al.
LANCET (2016)
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Elena Buzzetti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study
Dvir Froylich et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2016)
Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review
Pegah Golabi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies
Timothy J. Key et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
Guillaume Lassailly et al.
GASTROENTEROLOGY (2015)
Ezetimibe for the Treatment of Nonalcoholic Steatohepatitis: Assessment by Novel Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Randomized Trial (MOZART Trial)
Rohit Loomba et al.
HEPATOLOGY (2015)
The Effects of Bariatric Surgery on Pancreatic Lipid Metabolism and Blood Flow
Henri Honka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis
Sven Francque et al.
JOURNAL OF HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Declining liver graft quality threatens the future of liver transplantation in the United States
Eric S. Orman et al.
LIVER TRANSPLANTATION (2015)
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology
Guy Bower et al.
OBESITY SURGERY (2015)
The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: NASHOST prospective observational trial
P. Praveen Raj et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2015)
Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss
B. Gaborit et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease A 5-Year Controlled Longitudinal Study
Robert Caiazzo et al.
ANNALS OF SURGERY (2014)
Repair-Related Activation of Hedgehog Signaling in Stromal Cells Promotes Intrahepatic Hypothyroidism
Brittany N. Bohinc et al.
ENDOCRINOLOGY (2014)
Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications
Lars Sjostrom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
Gerald I. Shulman
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bariatric Surgery versus Intensive Medical Therapy for Diabetes REPLY
Philip R. Schauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance
Sabine Kahl et al.
PLOS ONE (2014)
Clinical approaches to non-alcoholic fatty liver disease
Katherine J. P. Schwenger et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study
Guangwei Li et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
Jessica K. Dyson et al.
FRONTLINE GASTROENTEROLOGY (2014)
Bariatric Surgery versus Intensive Medical Therapy for Diabetes-3-Year Outcomes
Philip R. Schauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study
Vincent Wai-Sun Wong et al.
ANNALS OF HEPATOLOGY (2013)
Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial
Russell J. de Souza et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Soluble Vascular Adhesion Protein-1 Correlates With Cardiovascular Risk Factors and Early Atherosclerotic Manifestations
Kristiina Aalto et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Effects of Bariatric Surgery on Cardiac Ectopic Fat Lesser Decrease in Epicardial Fat Compared to Visceral Fat Loss and No Change in Myocardial Triglyceride Content
Benedicte Gaborit et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects
Lena M. S. Carlsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
Philip R. Schauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Geltrude Mingrone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effect of Bariatric Surgery on Liver Fibrosis
Myriam Moretto et al.
OBESITY SURGERY (2012)
Improvement of Nonalcoholic Fatty Liver Disease After Bariatric Surgery in Morbidly Obese Chinese Patients
Chi-Ming Tai et al.
OBESITY SURGERY (2012)
Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol
E. L. Lim et al.
DIABETOLOGIA (2011)
Pioglitazone in the treatment of NASH: the role of adiponectin
A. Gastaldelli et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 Diabetes
Mariana Lazo et al.
DIABETES CARE (2010)
Surgical Treatment of Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease
R. A. Weiner
DIGESTIVE DISEASES (2010)
Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
Kittichai Promrat et al.
HEPATOLOGY (2010)
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
Giovanni Musso et al.
HEPATOLOGY (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease
Philippe Mathurin et al.
GASTROENTEROLOGY (2009)
Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography
Howard J. Willens et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Effects of bariatric surgery on nonalcoholic fatty liver disease: Preliminary findings after 2 years
Carlos K. Furuya et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Resolution of nonalcoholic steatohepatits after gastric bypass surgery
Xiuli Liu et al.
OBESITY SURGERY (2007)
Mechanisms linking obesity with cardiovascular disease
Luc F. Van Gaal et al.
NATURE (2006)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Renata Belfort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Weight loss and non-alcoholic fatty liver disease: Falls in gamma-glutamyl transferase concentrations are associated with histologic improvement
John B. Dixon et al.
OBESITY SURGERY (2006)
Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease
S Klein et al.
GASTROENTEROLOGY (2006)
Histological findings in the liver before and after gastric bypass
A Csendes et al.
OBESITY SURGERY (2006)
Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity
SR de Almeida et al.
OBESITY SURGERY (2006)
Non-alcoholic steatohepatitis: Effect of Roux-en-Y gastric bypass surgery
KB Barker et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Nonalcoholic fatty liver disease treated by gastroplasty
K Jaskiewicz et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome
SG Mattar et al.
ANNALS OF SURGERY (2005)
Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease
JM Clark et al.
OBESITY RESEARCH (2005)
Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery
CC Mottin et al.
OBESITY SURGERY (2005)
Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes
KF Petersen et al.
DIABETES (2005)
Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity
C Stratopoulos et al.
OBESITY SURGERY (2005)
Bariatric surgery: A systematic review and meta-analysis
H Buchwald et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
JB Dixon et al.
HEPATOLOGY (2004)
Metformin in non-alcoholic steatohepatitis
G Marchesini et al.
LANCET (2001)
分享论文
